Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What did the company say in public?!

"If this were the case as it relates to PTSC...then in no way could the BOD or management (insiders) be able to purchase stock with this information that was not public."

IF (and please note this is an incredible BIG IF!!!;-)) there is a clause, which says, there is more to come contingent on the USPTO outcome, they are not allowed to publish the contingency phrase because of the confidentality of the agreement.

And as long NOBODY knows the outcome of the USPTO, I don't understand this information as material, because it is "empty" (if you understand, what I'm trying to say). It becomes "full" and material, if the USPTO ruled.

BUT: As I said many times before, this is pure speculation for speculation sakes, just because nothing big is happening - IMHO there is a possiblity, nothing more.

So I'm not too serious with this topic, because it's another piece of the mysterious PTSC-tale - take care!

Share
New Message
Please login to post a reply